New Hampshire Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-870
Closed -$257K 177
2026
Q1
$257K Hold
870
0.05% 143
2025
Q4
$238K Sell
870
-541
-38% -$147K 0.05% 160
2025
Q3
$381K Hold
1,411
0.07% 137
2025
Q2
$389K Hold
1,411
0.08% 130
2025
Q1
$374K Sell
1,411
-84
-6% -$20.7K 0.09% 130
2024
Q4
$347K Sell
1,495
-859
-36% -$198K 0.07% 141
2024
Q3
$519K Hold
2,354
0.11% 116
2024
Q2
$463K Sell
2,354
-48
-2% -$9.92K 0.11% 116
2024
Q1
$517K Sell
2,402
-315
-12% -$66.2K 0.12% 110
2023
Q4
$572K Sell
2,717
-486
-15% -$104K 0.14% 107
2023
Q3
$641K Sell
3,203
-46
-1% -$9.14K 0.17% 92
2023
Q2
$602K Sell
3,249
-139
-4% -$25.7K 0.16% 94
2023
Q1
$649K Sell
3,388
-115
-3% -$20.8K 0.17% 94
2022
Q4
$589K Buy
+3,503
New +$609K 0.16% 98

Other funds holding CME

New Hampshire Trust's CME Position: Q2 2026 in Review

New Hampshire Trust sold out of CME Group (CME) in Q2 2026, closing a stake of 870 shares — an estimated $257K sold.

New Hampshire Trust first reported a position in CME in Q4 2022 and held it in 14 quarters. The position peaked at $649K in Q1 2023. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • New Hampshire Trust reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • New Hampshire Trust sold 870 CME Group shares in Q2 2026, an estimated $257K.
  • New Hampshire Trust first reported a position in CME Group in Q4 2022 and held it in 14 quarters.
  • New Hampshire Trust's CME Group position peaked at $649K in Q1 2023.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.